INGBAR, DAVID H.,RICH, TIMOTHY P.,SCHUMACHER, ROBERT J.,LEI, JIANXUN,BHARGAVA, MANEESH
申请号：
CA3090127
公开号：
CA3090127A1
申请日:
2019.01.31
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
A pharmaceutical composition for administering directly to the pulmonary tract of a subject includes a salt of triiodothyronine and a pharmaceutically acceptable buffer, adjusted to pH of 5.5-8.5. The composition can be administered prophylactically or therapeutically to a subject to treat lung inflammation or pulmonary edema.
